Featured Articles

1. Predictions For 2026 In Life Sciences 1/15/2026

   Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.

2. Decision-Ready Data Restores Clinical Teams' Confidence 1/14/2026

   The data underlying strategic decisions made by clinical teams often remain fragmented, backward-looking, or insufficiently validated. These teams need decision-ready data that brings clarity where it matters most.

3. No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure 1/14/2026

   This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.

4. Busting Through Patient Recruitment Barriers 12/8/2025

   Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.

5. Clinical Trial Starts Rose At Slower Pace In 2024 12/8/2025

   Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.

6. Retention Begins With Recruiting The Right-Fit Patients 11/13/2025

   Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.

7. 4 New Approvals In Q3 Across Gene, Cell, RNA Therapies 11/13/2025

   Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.

8. The Complexities Of Effective Patient Retention In Clinical Trials 11/7/2025

   Identifying and enrolling the right-fit patients from the outset is essential, but so is implementing comprehensive retention strategies that prioritize patient comfort, trust, and ongoing engagement.

9. What Is ICH GCP, And How Does It Impact Clinical Planning? 10/20/2025

   The updated ICH GCP guideline modernizes clinical trial standards, aligning with today’s technologies to enhance participant safety, data integrity, and risk-based trial design.

10. Clinical Trial Disclosure Noncompliance: What Is Its Impact On Pharma M&As? 10/20/2025

    Noncompliance with clinical trial disclosure regulations can jeopardize M&A deals. Understanding FDA and SEC requirements is critical to avoid red flags during due diligence.